Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They need cash so they can hit their finish and fill due in October...and they need to poly-line recertified for that to happen. They are still planning to send product to Argentina (filed the paperwork) - so regardless of what they in their PRs...someone in management is still pursuing ME/CFS where they have approvals to build on.
Right - not same Harry -- the calls is probably Harry Tajyar...but he owns stock historically under LLCs and aliases. Got into whatever this company is now through his relationship as IR for ADTM - don't know how far that relationship goes back - but at least to late 2014....just before the CEO was arrested for charges that I think he was cleared of. Strong was the second CEO to replace the original CEO.
I know most of these characters through their tenure at ADTM....not the group I would want to play ball with. At a minimum, this thing has been trying to right itself since 2015....and "officially" since mid 2017. Lotsa talk and lotsa noise bc of all the cannibis legislation....there are better ways to play the space.
HT has been peddling the same noise for years....do yourself a favor and don't listen. What IR firm threatens to sue someone for asking even unreasonable questions?
If you read IVVN then why are you posting her :)
You are incorrect. They were at Wainwright. Bassam did not make the trip, but Ryan did.
There are caveats around the valuation because the peer group is imperfect. There are business model, market cap, liquidity and profitability issues that need to be considered. Best to look at whole analysis.
Harry has a history of working with troubled companies. Look up ATLT...MYDX (that one's fun)....He's been trying to reboot ADTM for gosh more than a year that I can remember. Guess it still isn't done.
So you've spoken to Harry, huh?
That's his real name...(well one of them). What's he calling the firm now? It used to be IR Partners Inc.
In general, my guess is that Fidson needs a guarantee of funding from the non-profit/government entity that they can take to a bank as collateral (unless they are willing to front their own cash). That cash could then go to pay IMUN.
Under GAAP rules, IMUN can't recognize revenues until they know what the price/revenues are, have transferred ownership to Fidson with return and payment policies established and a realistic expectationthat they will be paid.
Fidson likely reports under IFRS - and I gather the revenue recognition rules are similar...but I am not certain....but it would be hard to check Fidson's books.
Here's where it could get interesting - depending on how IMUN might want to play their cards. They could cut corners a bunch of ways (aka channel stuffing)...essentially shipping/transferring ownership of product to Fidson but then granting Fidson some outsized return/payment conditions and then recognize the revenues on IMUN's books....
It is totally illegal (look at US vs. Michael Baker and Michael Gluk - the ARTC case) but it doesn't stop people from doing it....and it's not like PWC is auditing IMUN....and /or IMUN's auditor has the resources to physically inspect inventory - particularly that isn't in the US....and might be in the DR or might be in Africa....or might be stuck in customs somewhere. I want to think that if IMUN planned to pull that sort of stunt it would have happened already - but one never knows.
Think about how many times they've said something was approved but then come back a month (or year) later and say "Wait! There's more." More likely we might see some vague funding PR piece when insiders need to make some trades.
If I get time to look deeper or have other thoughts I'll come back.
Did you scroll down a bit?
https://m.sfgate.com/news/article/Norwalk-nonprofit-to-pay-651-000-to-settle-12823182.php
I don't know if she did it this year - but last year she circulated an email to a number of people to help pay for someone to attend one of the AIDs conferences.
Abeles' ability to add credibility seemed questionable to me at best....but, yes, he did have a pretty short tenure. Maybe he did some due diligence and said - see ya!
If it's the same attorney I worked with a year or so ago on IMUN - the attorney was very competent and efficient. NG has a tough time conveying information in an understandable way - and in my experience there are a lot of cooks who contribute to every PR. Getting one done and cleared is an unenviable task at best.
Take a look at the investor deck - it's an olio of past decks - the formatting doesn't even match...I don't think there's been any change to the deck since Apr/May of 17.
They had a writer late last year who was not an IR person - but a PR person....totallly different audience.
Freelanced through an agency in 2017. Stopped over a year ago.
Alas - having worked with NG -- she chooses to write (and rewrite) everything -- mostly from cutting and pasting.
And I question JS's success....I mean, if he is so good - why did he manage to make ADTM worse than it already was? Why pivot into a business combination that is in the SEC's crosshairs? Especially with the tons of bad-will the company has already created in the past three or four years.
I thought they hired some heavy-hitting writer back in February....this looks like it was simply written by their house counsel.
But more puzzling to me is why they are only filing the 8k now...since the date on the 8k is mid-April.
PS -- Average investors aren't supposed to read 8k's....that's why it's written in Vulcan geek speak. : )
Seems like most posters hate on NG. I only seek to illuminate the discrepancies in the company's statements.
Nope -- who's Ted Thorton? Related to Thurston Howell III?
They've been saying it for at least a year....
The market = investors or potential investors.
The group at UPenn seems to be the source of nearly all research on LDN. Why aren't other researchers following suit?
Hot air: The study only goes 12 weeks - there is no indication that patients might go off the listed meds without LDN as Crohns is often characterized by flareups followed by periods of remission.
Correlation is not the same as causation.
It is still a small study....with a very narrowly defined population and endpoint....what happens after 12 weeks? The market would react more positively if the study was not conducted by its biggest clinical proponent. Maybe if I dig into the data I can find more positive possibilities....but I think it's just more hot air.
I don't know if it's for triaging -- or simply to look bigger/more impressive. Think of all the comedy routines where someone answers a customer service call from an irate customer who wants to be transferred to the agents "manager".....and then the "manager" comes on the line and it is still the agent.
Again, there's nothing particularly wrong or underhanded - it's a lot like a celebrity using a pseudonym to book a hotel reservation. What matters in the end is whether investors get a timely response to their questions from and IR agency just as they would expect from an in-house IR person.
However, it seems that many of the posters are frustrated by the lack of communication/dissemination and that at least one poster seemed to get information that may violate reg FD....the first is frustrating - the latter may be in a grey zone as far as reg FD.
Twitter user handles are - if it's not already taken - go ahead and use it. Validation (if I remember correctly) is a basic "we're sending you a link to verify that this is the email attached to the twitter handle" -- or maybe there's two-factor authentication.....but my dog could have a twitter handle...as long as it connects to a live email account. And believe it or not -- some people have multiple email accounts - twitter handles - even FB profiles.
You misspelled the domain name -- That's why it didn't work - look at the undeliverable notice in your post
bmiller@irpartnersinc.com
Sloppy mistake it seems.
Called IRP offices over the years and finally realized that "Bill Miller" never returned my call...or even picked up the line. Also he's nowhere on the company's staff list.
It doesn't really matter -- I think they just did it to triage calls...but it's amusing - especially Bill Miller is better known as a portfolio manager.
Bill Miller was never a real person....just an email address that everything for IR Partners to go into. IRP still has an active website - try emailing the CEO - htajyar@irpartnersinc.com.
There was also another person listed on PRs a few months ago. Jchen@irpartnersinc.com, but his affiliation is unclear (at least originally) -- he was listed as part of Strong's people....but may be someone who worked at IRP and left -- hence the change back to Bill Miller as the contact.
Anyway - try this phone number - 855-FUND-420 -- it's not a usual IRP number -- so maybe it will get you connected with Strong.
They have/had a writer on retainer as of mid-February...not IRP....so it's not like NG is doing the writing...
Of course there's more news to follow -- the issue is whether it is really "new"s or partially forgotten leftovers.
Of course she doesn't have it together....but no one seems to...the question is why. I believe there have been plans for her to step down several times in the past two years.... that doesn't happen either.
Also -- how much is in non-insider hands (one way or another)...
Great -- Kenya accepted the application. It just means that all the paperwork is in order. Way to make news of nothing.
At some point, one has to ask why whatever this company will be called doesn't simply find a clean shell instead of trying to clean up ADTM for the shell.
Red Rock is definitely Tajyar/MyDx....IRP has written checks on the Red Rock account in the past.
Someone has to be skeptical. Sometimes even you. :)
Just a thought - feeling skeptical today
When (if) IMUN finally posts sales and ships product - I would look carefully to see if they are in fact, stuffing the channel. It is going to be difficult to verify that the sales are paid for and if there are extraordinary return provisions included in those sales. Remember -- it doesn't have to be paid in cash to be recorded as a sale. And companies ship product to distributors all the time without an upfront payment.
ARTC (now part of SNN) shipped tons of product to its distributors and recorded sales and actually paid distributors to hold product as a way of creating fake sales to drive demand. ARTC had major auditors (although I believe they were penalized for being in on the scheme) and all of this happened in the US.
Layer on IMUN's second-tier auditors and dealings with a distributor in another country - it will be very easy to manipulate reported figures. Not saying IMUN will -- but given all the excuses we hear about additional approvals needed - contracts with guaranteed minimums that don't seem to be hard and fast -- its simply an hypothesis to consider.
RJ is a quasi-insider. He's definitely a believer (at least publicly) - but it may have to do with how underwater he is in the shares personally - and possibly for others.
Only the first part. :)
Different strokes for different folks.
I corrected myself on AHAR ownership in my comment.
I don't dispute yourdump and pump theory - Although one could say that "the dump and pumpers" can keep this game going forever - which means one can only make money trading (and thereby supporting) this company.
I simply think that if one is going to invest money to support a drug or a company -- there are better people to support than those of IMUN.